Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure

Name: Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure
License: Public Domain

Tianjin Medical University Cancer Institute and Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

nsclc (non-small cell lung cancer), nsclc (advanced non-small cell lung cancer)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 136302
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.